DAAQ vs NERV
Comparison between Digital Asset Acquisition Corp - Class A (DAAQ, Company) and Minerva Neurosciences Inc (NERV, Company).
DAAQ is from the Financial Services sector, while NERV is from the Healthcare sector.
DAAQ vs NERV - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
DAAQ vs NERV - Historical Returns
Returns include dividend reinvestment.
DAAQ vs NERV - Annual Returns (2014 - 2026)
Returns include dividend reinvestment.
| Year | DAAQ | NERV |
|---|---|---|
| 2026 | -11.68% | +3.06% |
| 2025 | -2.31% | +74.78% |
| 2024 | N/A | -63.88% |
| 2023 | N/A | +307.28% |
| 2022 | N/A | -78.39% |
| 2021 | N/A | -66.34% |
| 2020 | N/A | -69.37% |
| 2019 | N/A | +2.75% |
| 2018 | N/A | +8.71% |
| 2017 | N/A | -48.51% |
| 2016 | N/A | +99.83% |
| 2015 | N/A | -0.65% |
| 2014 | N/A | -0.50% |
DAAQ vs NERV Drawdown Comparison
The maximum drawdown for DAAQ was -37.14%, occurring on Jul 29, 2026. This drawdown has not yet recovered.
The maximum drawdown for NERV was -98.86%, occurring on Apr 9, 2025. This drawdown has not yet recovered.
The current DAAQ drawdown is -17.88%. The current NERV drawdown is -96.56%.
| Rank | DAAQ | NERV |
|---|---|---|
| #1 | -37.14% Jun 24, 2025 - Jul 29, 2026 | -98.86% May 26, 2020 - Apr 9, 2025 |
| #2 | -0.56% Jun 13, 2025 - Jun 18, 2025 | -71.63% Sep 20, 2016 - May 21, 2020 |
| #3 | -0.19% Jun 11, 2025 - Jun 13, 2025 | -53.73% Sep 10, 2014 - May 26, 2016 |
| #4 | -0.10% Jun 6, 2025 - Jun 11, 2025 | -33.29% Jun 2, 2016 - Sep 20, 2016 |
| #5 | N/A | -17.13% Jul 28, 2014 - Sep 9, 2014 |
| #6 | N/A | -13.97% Jul 14, 2014 - Jul 28, 2014 |
| #7 | N/A | -4.07% May 26, 2016 - May 31, 2016 |
| #8 | N/A | -3.75% Jul 3, 2014 - Jul 10, 2014 |
| #9 | N/A | -1.99% May 21, 2020 - May 26, 2020 |
| #10 | N/A | -1.05% Jul 10, 2014 - Jul 14, 2014 |
| #11 | N/A | -0.83% Jul 1, 2014 - Jul 3, 2014 |
Correlation
Correlation between DAAQ and NERV is 0.00 which considered as a very weak or no correlation - the stocks move independently of each other.
Select Stocks to Compare
More Comparisons
Compare with similar stocks